🧬🇧🇷 THREAD | O DNA do Brasil foi decifrado.
E ele revela um país muito mais profundo, desigual e surpreendente do que imaginávamos.
Um estudo inédito mapeou o genoma completo de 2.723 brasileiros.
Spoiler: somos o povo com o mais alto grau de diversidade genética recente no mundo.
Acompanhe: 🧶👇
A valuable retrospective study on PD-L1 alteration after NAC in TNBC
🔹️22% of pts with residual tumors showed alteration in PD-L1
🔹️Almost all of these alterations were negative to positive changes
🔹️Platinum use associated with increased PD-L1
💥PD-L1 positivity after NAC associated with better RFS
@OncoAlert
https://t.co/ugNSltUSG0
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline
Who, when and which genetic test?
@OncoAlert
https://t.co/BZoqiYZoEF
Weekend review double feature! ✌️
Investigators outline #CRISPR screens resources that might facilitate the development and implementation of cancer #immunotherapies in the clinic.
https://t.co/Oj1YS9a6wC
Long non-coding RNAs: definitions, functions, challenges and recommendations
3 categories non-coding RNAs
1⃣<50 nt
small RNA
2⃣50-500 nt
PolIII/PolV transcripts, PolII small transcripts (snRNA snoRNA [miRNA?])
3⃣>500 nt
#LncRNA
🧐
@NatRevMCB 2024
https://t.co/iG7gi9wRTf
🔎 In a recent review, scientists explore the dynamic interactions among T and B cell subpopulations of varying phenotypes that contribute to the structural and functional diversity of tertiary #lymphoid structures.
https://t.co/vpZho64ylk
Incrível, lindo!
Naveguem neste mar das artes plásticas transformadas.
Creio ser IA. Muito bem feito.
Obras famosas, O Grito, Guernica, Dali, Chagal, Van Gogh vão surgindo de dentro das outras. É expressionante!
Curtam, comentem.
Nada substitui museus e os livros de arte, mas...
A brilliant review on the wealth of biomarkers for cancer and how they are enabling individualized treatment, improving prognosis
https://t.co/DCmY95W8np by @APassaroMD@peters_solange and colleagues @CellCellPress
Insights of #cancer burden from a large retrospective study: patients with double pathogenic variants in cancer predisposition genes showed greater burden than those with single gene variants https://t.co/EkRtw2VYI6 @DrHQRana#GIMO#MultiplePathogenicVariants#BreastCancer
A comprehensive 5★ perspective/review on cancer as a complex, systemic disease with all the hallmarks https://t.co/tV5VPHBmHA @CellCellPress by @CharlesSwanton and colleagues
Biallelic CHEK2 variants and increased risk of multiple primary malignancies - What are the implications for risk management guidelines? https://t.co/lEoSjVbfth #cancerpredisposition#cancergenetics @RMdeVoer
Today, I’m proud to say, our new paper on assortative mating was published in @NatureComms. (Link: https://t.co/ZHy3tVoVC3). Here are our key findings 🧵:
Epilepsy is the third leading contributor to the global burden of disease for neurological disorders and affects 65 million people worldwide.
#PurpleDay#EpilepsyAwareness
https://t.co/dSWgEn3UU8
One test to rule them all: Clinical #GenomeSequencing has superior sensitivity for CNVs and detection of multiple variant types including aneuploidies, mobile element insertions, and #UniparentalDisomy https://t.co/4KOp8C4ykQ
New #EditorsChoice: Genome-wide sequencing such as exome sequencing (ES) or genome sequencing (GS) may be more effective (and cost less!) than conventional diagnostic pathways in diagnosing children with neurodevelopmental disorders https://t.co/l9IiXq5BWI